37502610|t|Phosphatidylserine decarboxylase downregulation in uric acid-induced hepatic mitochondrial dysfunction and apoptosis.
37502610|a|The molecular mechanisms underlying uric acid (UA)-induced mitochondrial dysfunction and apoptosis have not yet been elucidated. Herein, we investigated underlying mechanisms of UA in the development of mitochondrial dysfunction and apoptosis. We analyzed blood samples of individuals with normal UA levels and patients with hyperuricemia. Results showed that patients with hyperuricemia had significantly elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, which may indicate liver or mitochondrial damage in patients with hyperuricemia. Subsequently, lipidomic analysis of mouse liver tissue mitochondria and human liver L02 cell mitochondria was performed. Compared with control group levels, high UA increased mitochondrial phosphatidylserine (PS) and decreased mitochondrial phosphatidylethanolamine (PE) levels, whereas the expression of mitochondrial phosphatidylserine decarboxylase (PISD) that mediates PS and PE conversion was downregulated. High UA levels also inhibited signal transducer and activator of transcription 3 (STAT3) phosphorylation as well as mitochondrial respiration, while inducing apoptosis both in vivo and in vitro. Treatment with allopurinol, overexpression of PISD, and lyso-PE (LPE) administration significantly attenuated the three above-described effects in vitro. In conclusion, UA may induce mitochondrial dysfunction and apoptosis through mitochondrial PISD downregulation. This study provides a new perspective on liver damage caused by hyperuricemia.
37502610	0	32	Phosphatidylserine decarboxylase	Gene	23761
37502610	51	60	uric acid	Chemical	MESH:D014527
37502610	77	102	mitochondrial dysfunction	Disease	MESH:D028361
37502610	154	163	uric acid	Chemical	MESH:D014527
37502610	165	167	UA	Chemical	MESH:D014527
37502610	177	202	mitochondrial dysfunction	Disease	MESH:D028361
37502610	296	298	UA	Chemical	MESH:D014527
37502610	321	346	mitochondrial dysfunction	Disease	MESH:D028361
37502610	415	417	UA	Chemical	MESH:D014527
37502610	443	456	hyperuricemia	Disease	MESH:D033461
37502610	492	505	hyperuricemia	Disease	MESH:D033461
37502610	543	567	alanine aminotransferase	Gene	2875
37502610	638	667	liver or mitochondrial damage	Disease	MESH:D056486
37502610	685	698	hyperuricemia	Disease	MESH:D033461
37502610	784	787	L02	CellLine	CVCL:6926
37502610	862	864	UA	Chemical	MESH:D014527
37502610	889	907	phosphatidylserine	Chemical	MESH:D010718
37502610	909	911	PS	Chemical	MESH:D010718
37502610	941	965	phosphatidylethanolamine	Chemical	MESH:C483858
37502610	967	969	PE	Chemical	MESH:C483858
37502610	1019	1051	phosphatidylserine decarboxylase	Gene	23761
37502610	1053	1057	PISD	Gene	23761
37502610	1073	1075	PS	Chemical	MESH:D010718
37502610	1080	1082	PE	Chemical	MESH:C483858
37502610	1118	1120	UA	Chemical	MESH:D014527
37502610	1143	1193	signal transducer and activator of transcription 3	Gene	20848
37502610	1195	1200	STAT3	Gene	20848
37502610	1323	1334	allopurinol	Chemical	MESH:D000493
37502610	1354	1358	PISD	Gene	23761
37502610	1364	1371	lyso-PE	Chemical	MESH:C008301
37502610	1373	1376	LPE	Chemical	MESH:C008301
37502610	1477	1479	UA	Chemical	MESH:D014527
37502610	1491	1516	mitochondrial dysfunction	Disease	MESH:D028361
37502610	1553	1557	PISD	Gene	23761
37502610	1615	1627	liver damage	Disease	MESH:D056486
37502610	1638	1651	hyperuricemia	Disease	MESH:D033461
37502610	Association	MESH:D028361	23761
37502610	Positive_Correlation	MESH:D014527	MESH:D028361
37502610	Positive_Correlation	MESH:D010718	MESH:D014527
37502610	Negative_Correlation	MESH:D014527	23761
37502610	Association	MESH:D010718	23761
37502610	Negative_Correlation	MESH:D000493	MESH:D014527
37502610	Negative_Correlation	MESH:C483858	MESH:D014527
37502610	Negative_Correlation	MESH:D000493	MESH:D033461
37502610	Positive_Correlation	MESH:D033461	2875
37502610	Association	MESH:C483858	23761
37502610	Negative_Correlation	MESH:D014527	20848

